Antiganglioside antibodies and their pathophysiological effects on Guillain-Barre syndrome and related disorders--A review
Open accessThe DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Abstract
Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy which can cause acute quadriplegia. Infection with micro-organisms, including Campylobacter jejuni (C. jejuni), Haemophilus influenzae, and Cytomegalovirus (CMV), is recognized as a main triggering event for the disease. Lipooligosaccharide (LOS) genes are responsible for the formation of human ganglioside-like LOS structures in infectious micro-organisms that can induce GBS. Molecular mimicry of LOSs on the surface of infectious agents and of ganglioside antigens on neural cells is thought to induce cross-reactive humoral and cellular immune responses. Patients with GBS develop antibodies against those gangliosides, resulting in autoimmune targeting of peripheral nerve sites, leading to neural damage. Heterogeneity of ganglioside expression in the peripheral nervous system (PNS) may underlie the differential clinical manifestation of the GBS variants. Recent studies demonstrate that some GBS sera react with ganglioside complexes consisting of two different gangliosides, such as GD1a and GD1b, or GM1 and GD1a, but not with each constituent ganglioside alone. The discovery of antiganglioside complex antibodies not only improves the detection rate of autoantibodies in GBS, but also provides a new concept in the antibody-antigen interaction through clustered carbohydrate epitopes. Although ganglioside mimicry is one of the possible etiological causes of GBS, unidentified factors may also contribute to the pathogenesis of GBS. While GBS is not considered a genetic disease, host factors, particularly human lymphocyte antigen type, appear to have a role in the pathogenesis of GBS following C. jejuni infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In the latter instance rare human immune responses against the ganglioside-like structures can even result in serious illness, with the complementfi xing antibodies damaging peripheral nerves (Guillain-Barré syndrome) (990 -991).”
From Biological roles of glycans (2017) · cites this paper as [991]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences
Parkhill, J., Wren, B. W., Mungall, K., Ketley, J. M., Churcher, C., Basham, D., Chillingworth, T., Davies, R. M., Feltwell, T., Holroyd, S., et al. (2000) · Nature · doi:10.1038/35001088 · Cited by 1,976
INDIAN JOURNAL OF MEDICAL RESEARCH.
(1931) · The Lancet · doi:10.1016/s0140-6736(00)82268-0 · Cited by 1,632
Fisher, M. (1956) · New England Journal of Medicine · doi:10.1056/nejm195607122550201 · Cited by 1,069
Glycosylation defining cancer malignancy: New wine in an old bottle
Hakomori, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172380699 · Cited by 960
Varki, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7390 · Cited by 946 · cited 1×
“Oligosaccharides, including gangliosides, are organized in clusters in the plasma membrane and are wrapped closely together to create rigid structures with multivalency in clustered saccharide patches (Varki 1994; Hakomori 2002; Willison 2005).”
BackgroundElectrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome
Hadden, R. D. M., Cornblath, D. R., Hughes, R. A. C., Zielasek, J., Hartung, H. ‐., Toyka, K. V., Swan, A. V., & The Plasma Exchange/Sandoglobulin Guillain‐Barré Syndrome Trial Group (1998) · Annals of Neurology · doi:10.1002/ana.410440512 · Cited by 942
Ho, T. W., Mishu, B., Li, C. Y., Gao, C. Y., Cornblath, D. R., Griffin, J. W., Asbury, A. K., Blaser, M. J., & McKhann, G. M. (1995) · Brain · doi:10.1093/brain/118.3.597 · Cited by 764
Journal of the Association of Physicians of India
(2023) · doi:10.5005/njem · Cited by 734
Peripheral neuropathies and anti-glycolipid antibodies
Willison, H. J. (2002) · Brain · doi:10.1093/brain/awf272 · Cited by 710
Chiba, A., Kusunoki, S., Obata, H., Machinami, R., & Kanazawa, I. (1993) · Neurology · doi:10.1212/wnl.43.10.1911 · Cited by 705
Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China
McKhann, G. M., Cornblath, D. R., Griffin, J. W., Ho, T. W., Li, C. Y., Jiang, Z., Wu, H. S., Zhaori, G., Liu, Y., Jou, L. P., et al. (1993) · Annals of Neurology · doi:10.1002/ana.410330402 · Cited by 625
Molecular mimicry and immune‐mediated diseases
Oldstone, M. B. A. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.13.1255 · Cited by 599
Campylobacter Species and Guillain-Barré Syndrome
Nachamkin, I., Allos, B. M., & Ho, T. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.555 · Cited by 590
Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome
Chiba, A., Kusunoki, S., Shimizu, T., & Kanazawa, I. (1992) · Annals of Neurology · doi:10.1002/ana.410310619 · Cited by 562
Acute motor axonal neuropathy: An antibody‐mediated attack on axolemma
Hafer‐Macko, C., Hsieh, S., Ho, T. W., Sheikh, K., Cornblath, D. R., Li, C. Y., McKhann, G. M., Asbury, A. K., & Griffin, J. W. (1996) · Annals of Neurology · doi:10.1002/ana.410400414 · Cited by 512
Yuki, N., Susuki, K., Koga, M., Nishimoto, Y., Odaka, M., Hirata, K., Taguchi, K., Miyatake, T., Furukawa, K., Kobata, T., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402391101 · Cited by 498
Mechanisms for the induction of autoimmunity by infectious agents
Wucherpfennig, K. W. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14235 · Cited by 435
Evidence for a system of general protein glycosylation in Campylobacter jejuni
Szymanski, C. M., Yao, R., Ewing, C. P., Trust, T. J., & Guerry, P. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01415.x · Cited by 412
Pathology of the motor‐sensory axonal Guillain‐Barré syndrome
Griffin, J. W., Li, C. Y., Ho, T. W., Tian, M., Gao, C. Y., Xue, P., Mishu, B., Cornblath, D. R., Macko, C., McKhann, G. M., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410390105 · Cited by 403
Preceding infections, immune factors, and outcome in Guillain–Barré syndrome
Hadden, R. D. M., Karch, H., Hartung, H.-P., Zielasek, J., Weissbrich, B., Schubert, J., Weishaupt, A., Cornblath, D. R., Swan, A. V., Hughes, R. A. C., et al. (2001) · Neurology · doi:10.1212/wnl.56.6.758 · Cited by 375
Susuki, K., Rasband, M. N., Tohyama, K., Koibuchi, K., Okamoto, S., Funakoshi, K., Hirata, K., Baba, H., & Yuki, N. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4401-06.2007 · Cited by 373
Schembri, M. (2016) · European Society of Radiology · doi:10.1594/ecr2016/c-1350 · Cited by 367
Mechanisms for the induction of autoimmunity by infectious agents
Wucherpfennig, K. W. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200114235 · Cited by 353
Ogawara, K., Kuwabara, S., Mori, M., Hattori, T., Koga, M., & Yuki, N. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200010)48:4<624::aid-ana9>3.3.co;2-f · Cited by 333
Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barr� syndrome
Ho, T. W., Willison, H. J., Nachamkin, I., Li, C. Y., Veitch, J., Ung, H., Wang, G. R., Liu, R. C., Cornblath, D. R., Asbury, A. K., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199902)45:2<168::aid-ana6>3.0.co;2-6 · Cited by 329
Yuki, N., Yamada, M., Koga, M., Odaka, M., Susuki, K., Tagawa, Y., Ueda, S., Kasama, T., Ohnishi, A., Hayashi, S., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1012 · Cited by 323
Campylobacter jejuni infections and anti‐GM1 antibodies in guillain‐barré syndrome
Jacobs, B. C., van Doorn, P. A., Tio‐Gillen, A. P., Visser, L. H., van der Meché, F. G. A., Schmitz, P. I. M., Herbrink, P., & Hooijkaas, H. (1996) · Annals of Neurology · doi:10.1002/ana.410400209 · Cited by 314
Kuwabara, S., Yuki, N., Koga, M., Hattori, T., Matsuura, D., Miyake, M., & Noda, M. (1998) · Annals of Neurology · doi:10.1002/ana.410440210 · Cited by 311
Chiba, A., Kusunoki, S., Obata, H., Machinami, R., & Kanazawa, I. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01123-7 · Cited by 288
Gilbert, M., Karwaski, M.-F., Bernatchez, S., Young, N. M., Taboada, E., Michniewicz, J., Cunningham, A.-M., & Wakarchuk, W. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108452200 · Cited by 284
Rees, J. H., Gregson, N. A., & Hughes, R. A. C. (1995) · Annals of Neurology · doi:10.1002/ana.410380516 · Cited by 266
Weiner, H. L., Lemere, C. A., Maron, R., Spooner, E. T., Grenfell, T. J., Mori, C., Issazadeh, S., Hancock, W. W., & Selkoe, D. J. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200010)48:4<567::aid-ana3>3.0.co;2-w · Cited by 263
Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome
Griffin, J. W., Li, C. Y., Macko, C., Ho, T. W., Hsieh, S. T., Xue, P., Wang, F. A., Cornblath, D. R., McKhann, G. M., & Asbury, A. K. (1996) · Journal of Neurocytology · doi:10.1007/bf02284784 · Cited by 262
The effect of duration of muscle denervation on functional recovery in the rat model
Kobayashi, J., Mackinnon, S. E., Watanabe, O., Ball, D. J., Ming Gu, X., Hunter, D. A., & Kuzon, W. M. (1997) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199707)20:7<858::aid-mus10>3.0.co;2-o · Cited by 260
Biosynthesis of Ganglioside Mimics in Campylobacter jejuni OH4384
Gilbert, M., Brisson, J.-R., Karwaski, M.-F., Michniewicz, J., Cunningham, A.-M., Wu, Y., Young, N. M., & Wakarchuk, W. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3896 · Cited by 257
Unusual Clinical Variants and Signs in Guillain-Barre Syndrome
Ropper, A. H. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520110044012 · Cited by 254
Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model
Halstead, S. K., Zitman, F. M. P., Humphreys, P. D., Greenshields, K., Verschuuren, J. J., Jacobs, B. C., Rother, R. P., Plomp, J. J., & Willison, H. J. (2008) · Brain · doi:10.1093/brain/awm316 · Cited by 239
Linton, D., Gilbert, M., Hitchen, P. G., Dell, A., Morris, H. R., Wakarchuk, W. W., Gregson, N. A., & Wren, B. W. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.02020.x · Cited by 234
Antecedent infections in Fisher syndrome: A common pathogenesis of molecular mimicry
Koga, M., Gilbert, M., Li, J., Koike, S., Takahashi, M., Furukawa, K., Hirata, K., & Yuki, N. (2005) · Neurology · doi:10.1212/01.wnl.0000160399.08456.7c · Cited by 233
Godschalk, P. C. R., Heikema, A. P., Gilbert, M., Komagamine, T., Ang, C. W., Glerum, J., Brochu, D., Li, J., Yuki, N., Jacobs, B. C., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci15707 · Cited by 231
Gene Expression Profile of Campylobacter jejuni in Response to Growth Temperature Variation
Stintzi, A. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.6.2009-2016.2003 · Cited by 230
Chiu, C. P. C., Watts, A. G., Lairson, L. L., Gilbert, M., Lim, D., Wakarchuk, W. W., Withers, S. G., & Strynadka, N. C. J. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb720 · Cited by 214
Goodyear, C. S., O’Hanlon, G. M., Plomp, J. J., Wagner, E. R., Morrison, I., Veitch, J., Cochrane, L., Bullens, R. W. M., Molenaar, P. C., Conner, J., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6837 · Cited by 210
Incidence of Guillain-Barré Syndrome following Infection with Campylobacter jejuni
McCarthy, N., & Giesecke, J. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.6.610 · Cited by 202
Susuki, K., Baba, H., Tohyama, K., Kanai, K., Kuwabara, S., Hirata, K., Furukawa, K., Furukawa, K., Rasband, M. N., & Yuki, N. (2007) · Glia · doi:10.1002/glia.20503 · Cited by 201
Experimental sensory neuropathy induced by sensitization with ganglioside GD1b
Kusunoki, S., Shimizu, J., Chiba, A., Ugawa, Y., Hitoshi, S., & Kanazawa, I. (1996) · Annals of Neurology · doi:10.1002/ana.410390404 · Cited by 199
Miller Fisher anti-GQ1b antibodies: ?-Latrotoxin-like effects on motor end plates
Plomp, J. J., Molenaar, P. C., O'Hanlon, G. M., Jacobs, B. C., Veitch, J., Daha, M. R., Van Doorn, P. A., Van Der Mech�, F. G. A., Vincent, A., Morgan, B. P., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199902)45:2<189::aid-ana9>3.0.co;2-t · Cited by 196
Tam, C. C., O'Brien, S. J., Petersen, I., Islam, A., Hayward, A., & Rodrigues, L. C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000344 · Cited by 193
Godschalk, P. C. R., Heikema, A. P., Gilbert, M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200415707 · Cited by 193
Localization of major gangliosides in the PNS: implications for immune neuropathies
Gong, Y., Tagawa, Y., Lunn, M. P. T., Laroy, W., Heffer‐Lauc, M., Li, C. Y., Griffin, J. W., Schnaar, R. L., & Sheikh, K. A. (2002) · Brain · doi:10.1093/brain/awf258 · Cited by 192
O'Hanlon, G. M. (2001) · Brain · doi:10.1093/brain/124.5.893 · Cited by 192
Svennerholm, L., Måansson, J.-E., & Li, Y.-T. (1973) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)44435-9 · Cited by 184
N‐acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain‐Barré syndrome
Kusunoki, S., Chiba, A., Kon, K., Ando, S., Arisawa, K., Tate, A., & Kanazawa, I. (1994) · Annals of Neurology · doi:10.1002/ana.410350510 · Cited by 180
Visser, L. H., Van Der Meché, F. G. A., Van Doorn, P. A., Meulstee, J., Jacobs, B. C., Oomes, P. G., & Kleyweg, R. P. (1995) · Brain · doi:10.1093/brain/118.4.841 · Cited by 177
Enders, U., Karch, H., Toyka, K. V., Michels, M., Zielasek, J., Pette, M., Heesemann, J., & Hartung, H. (1993) · Annals of Neurology · doi:10.1002/ana.410340208 · Cited by 171
Ganglioside complexes as new target antigens in Guillain–Barré syndrome
Kaida, K., Morita, D., Kanzaki, M., Kamakura, K., Motoyoshi, K., Hirakawa, M., & Kusunoki, S. (2004) · Annals of Neurology · doi:10.1002/ana.20222 · Cited by 170
Self-citationRegulation of ganglioside biosynthesis in the nervous system
Yu, R. K. (2004) · The Journal of Lipid Research · doi:10.1194/jlr.r3000020-jlr200 · Cited by 169
Self-citationGuerry, P., Ewing, C. P., Hickey, T. E., Prendergast, M. M., & Moran, A. P. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.6656-6662.2000 · Cited by 168
The immunopathogenesis of Miller Fisher syndrome
Willison, H. J., & O’Hanlon, G. M. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00213-1 · Cited by 167
The CD1 family of lipid antigen-presenting molecules
Porcelli, S. A., Segelke, B. W., Sugita, M., Wilson, I. A., & Brenner, M. B. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01289-4 · Cited by 166
Patterns of recovery in the Guillain-Barre syndromes
Ho, T. W., Li, C. Y., Cornblath, D. R., Gao, C. Y., Asbury, A. K., Griffin, J. W., & McKhann, G. M. (1997) · Neurology · doi:10.1212/wnl.48.3.695 · Cited by 165
Continuous Spectrum of Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome
Nagashima, T., Koga, M., Odaka, M., Hirata, K., & Yuki, N. (2007) · Archives of Neurology · doi:10.1001/archneur.64.10.1519 · Cited by 160
Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia
Kusunoki, S., Chiba, A., & Kanazawa, I. (1999) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199908)22:8<983::aid-mus1>3.0.co;2-v · Cited by 157
Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia
Kusunoki, S., Chiba, A., & Kanazawa, I. (1999) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199908)22:8<1071::aid-mus10>3.0.co;2-0 · Cited by 156
Linton, D., Karlyshev, A. V., Hitchen, P. G., Morris, H. R., Dell, A., Gregson, N. A., & Wren, B. W. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01780.x · Cited by 153
Guillain‐Barré Syndrome and Influenza Virus Infection
Sivadon‐Tardy, V., Orlikowski, D., Porcher, R., Sharshar, T., Durand, M., Enouf, V., Rozenberg, F., Caudie, C., Annane, D., van der Werf, S., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/594124 · Cited by 153
Halstead, S. K., O'Hanlon, G. M., Humphreys, P. D., Morrison, D. B., Morgan, B. P., Todd, A. J., Plomp, J. J., & Willison, H. J. (2004) · Brain · doi:10.1093/brain/awh231 · Cited by 152
Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release
Roberts, M. T. M., Vincent, A. C., Newsom–Davis, J., & Willison, H. J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92694-8 · Cited by 151
Godschalk, P. C. R., Kuijf, M. L., Li, J., St. Michael, F., Ang, C. W., Jacobs, B. C., Karwaski, M.-F., Brochu, D., Moterassed, A., Endtz, H. P., et al. (2007) · Infection and Immunity · doi:10.1128/iai.00872-06 · Cited by 146
The distribution of ganglioside-like moieties in peripheral nerves
Sheikh, K. A., Deerinck, T. J., Ellisman, M. H., & Griffin, J. W. (1999) · Brain · doi:10.1093/brain/122.3.449 · Cited by 145
Ganglioside mimicry and peripheral nerve disease
Yuki, N. (2007) · Muscle & Nerve · doi:10.1002/mus.20762 · Cited by 142
Yu, R. K., Usuki, S., & Ariga, T. (2006) · Infection and Immunity · doi:10.1128/iai.00967-06 · Cited by 142
Self-citationThe galE Gene of Campylobacter jejuni Is Involved in Lipopolysaccharide Synthesis and Virulence
Fry, B. N., Feng, S., Chen, Y.-Y., Newell, D. G., Coloe, P. J., & Korolik, V. (2000) · Infection and Immunity · doi:10.1128/iai.68.5.2594-2601.2000 · Cited by 141
T-Cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barr� syndrome
Hartung, H., & Toyka, K. V. (1990) · Annals of Neurology · doi:10.1002/ana.410270716 · Cited by 137
Sheikh, K. A., Nachamkin, I., Ho, T. W., Willison, H. J., Veitch, J., Ung, H., Nicholson, M., Li, C. Y., Wu, H. S., Shen, B. Q., et al. (1998) · Neurology · doi:10.1212/wnl.51.2.371 · Cited by 135
Goodfellow, J. A., Bowes, T., Sheikh, K. A., Odaka, M., Halstead, S. K., Humphreys, P. D., Wagner, E. R., Yuki, N., Furukawa, K., Furukawa, K., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4279-04.2005 · Cited by 134
Anti-GM1 antibodies in patients with Guillain-Barre syndrome.
van den Berg, L. H., Marrink, J., de Jager, A. E., et al. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.1.8 · Cited by 129
Koga, M., Gilbert, M., Takahashi, M., Li, J., Koike, S., Hirata, K., & Yuki, N. (2006) · The Journal of Infectious Diseases · doi:10.1086/499969 · Cited by 126
Ang, C. W., Laman, J. D., Willison, H. J., Wagner, E. R., Endtz, H. P., De Klerk, M. A., Tio-Gillen, A. P., Van den Braak, N., Jacobs, B. C., & Doorn, P. A. V. (2002) · Infection and Immunity · doi:10.1128/iai.70.3.1202-1208.2002 · Cited by 124
Anti-ganglioside complex antibodies associated with severe disability in GBS
Kaida, K.-I., Morita, D., Kanzaki, M., Kamakura, K., Motoyoshi, K., Hirakawa, M., & Kusunoki, S. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.09.013 · Cited by 122
Self-citationBullens, R. W. M., O’Hanlon, G. M., Wagner, E., Molenaar, P. C., Furukawa, K., Furukawa, K., Plomp, J. J., & Willison, H. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-16-06876.2002 · Cited by 119
Bacterial Infections Promote T Cell Recognition of Self-Glycolipids
Libero, G. D., Moran, A. P., Gober, H.-J., Rossy, E., Shamshiev, A. T., Chelnokova, O., Mazorra, Z., Vendetti, S., Sacchi, A., Prendergast, M. M., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.04.013 · Cited by 115
Nachamkin, I., Shadomy, S. V., Moran, A. P., Cox, N., Fitzgerald, C., Ung, H., Corcoran, A. T., Iskander, J. K., Schonberger, L. B., & Chen, R. T. (2008) · The Journal of Infectious Diseases · doi:10.1086/589624 · Cited by 114
Localization of GM1 and GD1b antigens in the human peripheral nervous system
Kusunoki, S., Chiba, A., Tai, T., Tai, T., & Kanazawa, I. (1993) · Muscle & Nerve · doi:10.1002/mus.880160710 · Cited by 113
Campylobacter gene polymorphism as a determinant of clinical features of Guillain–Barré syndrome
Koga, M., Takahashi, M., Masuda, M., Hirata, K., & Yuki, N. (2005) · Neurology · doi:10.1212/01.wnl.0000176914.70893.14 · Cited by 112
Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome
Halstead, S. K., Humphreys, P. D., Goodfellow, J. A., Wagner, E. R., Smith, R. A. G., & Willison, H. J. (2005) · Annals of Neurology · doi:10.1002/ana.20546 · Cited by 112
GM1b is a new member of antigen for serum antibody in Guillain-Barre syndrome
Kusunoki, S., Iwamori, M., Chiba, A., Hitoshi, S., Arita, M., & Kanazawa, I. (1996) · Neurology · doi:10.1212/wnl.47.1.237 · Cited by 109
Anti-GT1a IgG in Guillain-Barre syndrome
Koga, M. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.6.767 · Cited by 108
Anti-ganglioside complex antibodies in Miller Fisher syndrome
Kaida, K.-I., Kanzaki, M., Morita, D., Kamakura, K., Motoyoshi, K., Hirakawa, M., & Kusunoki, S. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.087940 · Cited by 107
Self-citationRhijn, I. V., den Berg, L. H. V., Bosboom, W. M., Otten, H. G., & Logtenberg, T. (2000) · Brain · doi:10.1093/brain/123.10.2020 · Cited by 104
Nachamkin, I., Liu, J., Li, M., et al. (2002) · Infection and Immunity · doi:10.1128/iai.70.9.5299-5303.2002 · Cited by 104
Rees, J. H., Vaughan, R. W., Kondeatis, E., & Hughes, R. A. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00102-8 · Cited by 103
Guillain-Barr� syndrome: Its epidemiology and associations with influenza vaccination
Schonberger, L. B., Hurwitz, E. S., Katona, P. G., Holman, R. C., & Bregman, D. J. (1981) · Annals of Neurology · doi:10.1002/ana.410090707 · Cited by 98
Willison, H. J., O’Hanlon, G. M., Paterson, G., Veitch, J., Wilson, G., Roberts, M., Tang, T., & Vincent, A. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118529 · Cited by 98
O’Hanlon, G. M., Humphreys, P. D., Goldman, R. S., Halstead, S. K., Bullens, R. W. M., Plomp, J. J., Ushkaryov, Y. A., & Willison, H. J. (2003) · Brain · doi:10.1093/brain/awg254 · Cited by 98
Abnormality of circulating CD4+CD25+ regulatory T cell in patients with Guillain–Barré syndrome
Chi, L.-J., Wang, H., Zhang, Y., et al. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.09.034 · Cited by 97
Acute motor axonal neuropathy rabbit model: Immune attack on nerve root axons
Susuki, K., Nishimoto, Y., Yamada, M., Baba, M., Ueda, S., Hirata, K., & Yuki, N. (2003) · Annals of Neurology · doi:10.1002/ana.33333 · Cited by 96
Guillain-Barre syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a
Kaida, K., Kusunoki, S., Kamakura, K., Motoyoshi, K., & Kanazawa, I. (2000) · Brain · doi:10.1093/brain/123.1.116 · Cited by 96
Self-citationKieseier, B. C., Clements, J. M., Pischel, H. B., Wells, G. M. A., Miller, K., Gearing, A. J. H., & Hartung, H. ‐. (1998) · Annals of Neurology · doi:10.1002/ana.410430404 · Cited by 95
Susceptibility to Guillain–Barré syndrome is associated to polymorphisms of CD1 genes
Caporale, C. M., Papola, F., Fioroni, M. A., Aureli, A., Giovannini, A., Notturno, F., Adorno, D., Caporale, V., & Uncini, A. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.05.018 · Cited by 91
Lehmann, H. C., Lopez, P. H. H., Zhang, G., Ngyuen, T., Zhang, J., Kieseier, B. C., Mori, S., & Sheikh, K. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4017-06.2007 · Cited by 90
Putzu, G. A., Figarella‐Branger, D., Bouvier, C., Liprandi, A., Bianco, N., & Pellissier, J. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00328-7 · Cited by 90
Ilyas, A. A., Li, S. C., Chou, D. K. H., Li, Y. T., Jungalwala, F. B., Dalakas, M. C., & Quarles, R. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68935-5 · Cited by 89
IgG receptor IIa alleles determine susceptibility and severity of Guillain-Barré syndrome
van der Pol, W. L., van den Berg, L. H., Scheepers, R. H. M., van der Bom, J. G., van Doorn, P. A., van Koningsveld, R., van den Broek, M. C. L., Wokke, J. H. J., & van de Winkel, J. G. J. (2000) · Neurology · doi:10.1212/wnl.54.8.1661 · Cited by 86
Csurhes, P. A. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.052282 · Cited by 86
Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies
Ang, C. W., Yuki, N., Jacobs, B. C., Koga, M., Van Doorn, P. A., Schmitz, P. I. M., & Van Der Meché, F. G. A. (1999) · Neurology · doi:10.1212/wnl.53.9.2122 · Cited by 84
The lipopolysaccharide biosynthesis locus of Campylobacter jejuni 81116
Fry, B. N., Korolik, V., ten Brinke, A., et al. (1998) · Microbiology · doi:10.1099/00221287-144-8-2049 · Cited by 83
Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: Relation to Miller Fisher syndrome
Yuki, N., Susuki, K., & Hirata, K. (2000) · Neurology · doi:10.1212/wnl.54.9.1851 · Cited by 83
Magira, E. E., Papaioakim, M., Nachamkin, I., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3074 · Cited by 82
Koga, M., Yuki, N., Ariga, T., Morimatsu, M., & Hirata, K. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00016-2 · Cited by 82
Self-citationYoneda, Y., Tokui, K., Hanihara, T., Kitagaki, H., Tabuchi, M., & Mori, E. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199906)45:6<736::aid-ana7>3.0.co;2-f · Cited by 78
A Campylobacter jejuni gene associated with immune-mediated neuropathy
van Belkum, A., van den Braak, N., Godschalk, P. C. R., Ang, W., Jacobs, B. C., Gilbert, M., Wakarchuk, W. W., Verbrugh, H. A., & Endtz, H. P. (2001) · Nature Medicine · doi:10.1038/89831 · Cited by 76
GM1/GalNAc-GD1a complex: A target for pure motor Guillain-Barré syndrome
Kaida, K., Sonoo, M., Ogawa, G., Kamakura, K., Ueda-Sada, M., Arita, M., Motoyoshi, K., & Kusunoki, S. (2008) · Neurology · doi:10.1212/01.wnl.0000335160.72184.7d · Cited by 74
Self-citationClinical correlates of serum anti-GT1a IgG antibodies
Nagashima, T., Koga, M., Odaka, M., Hirata, K., & Yuki, N. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.01.005 · Cited by 74
Press, R., Pashenkov, M. V., Jin, J., & Link, H. (2003) · Journal of Clinical Immunology · doi:10.1023/a:1024532715775 · Cited by 72
Kanipes, M. I., Papp-Szabó, E., Guerry, P., & Monteiro, M. A. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.9.3273-3279.2006 · Cited by 72
Severity of Guillain–Barré syndrome is associated with Fcγ Receptor III polymorphisms
van Sorge, N. M., van der Pol, W. L., Jansen, M., Geleijns, K. P. W., Kalmijn, S., Hughes, R. A., Rees, J. H., Pritchard, J., Vedeler, C. A., Myhr, K., et al. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.01.016 · Cited by 71
Hao, Q., Saida, T., Yoshino, H., Kuroki, S., Nukina, M., & Saida, K. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199906)45:6<758::aid-ana10>3.0.co;2-n · Cited by 70
Créange, A., Bélec, L., Clair, B., et al. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00075-6 · Cited by 69
Glycobiology of the neuromuscular junction
Martin, P. T. (2003) · Journal of Neurocytology · doi:10.1023/b:neur.0000020632.41508.83 · Cited by 69
Mizoguchi, K., Hase, A., Obi, T., Matsuoka, H., Takatsu, M., Nishimura, Y., Irie, F., Seyama, Y., & Hirabayashi, Y. (1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.9.1121 · Cited by 69
Halstead, S. K., Morrison, I., O’Hanlon, G. M., Humphreys, P. D., Goodfellow, J. A., Plomp, J. J., & Willison, H. J. (2005) · Glia · doi:10.1002/glia.20228 · Cited by 68
GD1b-specific antibody induces ataxia in Guillain-Barré syndrome
Kaida, K., Kamakura, K., Ogawa, G., Ueda, M., Motoyoshi, K., Arita, M., & Kusunoki, S. (2008) · Neurology · doi:10.1212/01.wnl.0000317093.57106.33 · Cited by 67
Self-citationAcute motor neuropathy with antibodies to GM1 ganglioside
Gregson, N. A., Jones, D. M., Thomas, P. K., & Willison, H. J. (1991) · Journal of Neurology · doi:10.1007/bf00314652 · Cited by 66
Phongsisay, V., Susuki, K., Matsuno, K., Yamahashi, T., Okamoto, S., Funakoshi, K., Hirata, K., Shinoda, M., & Yuki, N. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.016 · Cited by 65
HLA class II alleles are not a general susceptibility factor in Guillain–Barré syndrome
Geleijns, K. P. W., Schreuder, G. M. T., Jacobs, B. C., Sintnicolaas, K., van Koningsveld, R., Meulstee, J., Laman, J. D., & van Doorn, P. A. (2005) · Neurology · doi:10.1212/01.wnl.0000148727.02732.01 · Cited by 65
HLA‐B35 and acute axonal polyneuropathy following Campylobacter infection
Yuki, N., Sato, S., Itoh, T., & Miyatake, T. (1991) · Neurology · doi:10.1212/wnl.41.10.1561 · Cited by 65
Acute sensory ataxic neuropathy associated with monospecific anti-GD1b IgG antibody
Pan, C., Yuki, N., Koga, M., Chiang, M., & Hsieh, S. (2001) · Neurology · doi:10.1212/wnl.57.7.1316 · Cited by 64
The distribution of CD1 molecules in inflammatory neuropathy
Khalili-Shirazi, A., Gregson, N. A., Londei, M., Summers, L., & Hughes, R. A. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00121-x · Cited by 61
O’Hanlon, G. M., Paterson, G. J., Veitch, J., Wilson, G., & Willison, H. J. (1998) · Acta Neuropathologica · doi:10.1007/s004010050847 · Cited by 60
Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes
Kanzaki, M., Kaida, K., Ueda, M., Morita, D., Hirakawa, M., Motoyoshi, K., Kamakura, K., & Kusunoki, S. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.142950 · Cited by 60
Self-citationAriga, T., & Yu, R. K. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20395 · Cited by 60
Self-citationRecurrent Miller Fisher syndrome: clinical and laboratory features and HLA antigens
Chida, K., Nomura, H., Konno, H., et al. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00095-7 · Cited by 57
Anti-ganglioside antibodies alter presynaptic release and calcium influx
Buchwald, B., Zhang, G., Vogt-Eisele, A. K., Zhang, W., Ahangari, R., Griffin, J. W., Hatt, H. H., Toyka, K. V., & Sheikh, K. A. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.008 · Cited by 55
Structural requirements of anti-GD1a antibodies determine their target specificity
López, P. H. H., Zhang, G., Bianchet, M. A., Schnaar, R. L., & Sheikh, K. A. (2008) · Brain · doi:10.1093/brain/awn074 · Cited by 55
Guillain–Barré syndrome associated with IgG monospecific to ganglioside GD1b
Miyazaki, T., Kusunoki, S., Kaida, K.-I., Shiina, M., & Kanazawa, I. (2001) · Neurology · doi:10.1212/wnl.56.9.1227 · Cited by 55
Self-citationThe occurrence of Guillain-Barre syndrome within families
Geleijns, K. P. W., Brouwer, B., Jacobs, B. C., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000143055.09646.31 · Cited by 55
Oldfield, N. J., Moran, A. P., Millar, L. A., et al. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.8.2100-2107.2002 · Cited by 53
HLA-DR antigens in Mexican patients with Guillain-Barré syndrome
Gorodezky, C., Varela, B., Castro‐Escobar, L. E., et al. (1983) · Journal of Neuroimmunology · doi:10.1016/0165-5728(83)90058-9 · Cited by 53
GalNAc-GD1a in human peripheral nerve
Kaida, K.-I., Kusunoki, S., Kamakura, K., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000081229.88862.c6 · Cited by 53
Self-citationHarness, J., & McCombe, P. (2008) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2007.09.016 · Cited by 52
Usuki, S., Sanchez, J., Ariga, T., Utsunomiya, I., Taguchi, K., Rivner, M. H., & Yu, R. K. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.01.007 · Cited by 52
Self-citationHLA and T-cell receptor gene polymorphisms in Guillain-Barre syndrome
J., J., Nishimura, M., Mines, H., Kuroki, S., Nukina, M., Ohta, M., Saji, H., Obayashi, H., Saida, T., Kawakami, H., et al. (1998) · Neurology · doi:10.1212/wnl.51.2.379 · Cited by 52
Binding of antibodies against GM1 and GD1b in human peripheral nerve
Kusunoki, S., Mashiko, H., Mochizuki, N., Chiba, A., Arita, M., Hitoshi, S., & Kanazawa, I. (1997) · Muscle & Nerve · Cited by 52
Origin of ganglioside complex antibodies in Guillain–Barré syndrome
Kuijf, M. L., Godschalk, P. C. R., Gilbert, M., Endtz, H. P., Tio‐Gillen, A. P., Ang, C. W., van Doorn, P. A., & Jacobs, B. C. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.05.014 · Cited by 51
O’Hanlon, G. M., Paterson, G. J., Wilson, G., Doyle, D., McHardie, P., & Willison, H. J. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199602000-00007 · Cited by 51
Identification of a Sialate O-Acetyltransferase from Campylobacter jejuni
Houliston, R. S., Endtz, H. P., Yuki, N., Li, J., Jarrell, H. C., Koga, M., van Belkum, A., Karwaski, M.-F., Wakarchuk, W. W., & Gilbert, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512183200 · Cited by 51
Genetic polymorphisms of macrophage-mediators in Guillain–Barré syndrome
Geleijns, K. P. W., Emonts, M., Laman, J. D., van Rijs, W., van Doorn, P. A., Hermans, P. W. M., & Jacobs, B. C. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.07.008 · Cited by 50
Yonekura, K., Yokota, S., Tanaka, S., KUBOTA, H. Y., Fujii, N., Matsumoto, H., & Chiba, S. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.07.017 · Cited by 50
Brooke, J. S., & Valvano, M. A. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.11.3339-3341.1996 · Cited by 50
Radhakrishnan, V. V., Sumi, M. G., Reuben, S., et al. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00179.x · Cited by 49
Guillain–Barré syndrome with IgM antibody to the ganglioside GalNAc–GD1a
Kaida, K., Kusunoki, S., Kamakura, K., et al. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00451-3 · Cited by 47
Self-citationMcCombe, P., Csurhes, P. A., & Greer, J. M. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.07.017 · Cited by 47
Schmidt‐Ott, R., Schmidt, H., Feldmann, S., Brass, F., Krone, B., & Groß, U. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00065-06 · Cited by 47
Phongsisay, V., Perera, V. N., & Fry, B. N. (2006) · Microbiology · doi:10.1099/mic.0.29230-0 · Cited by 47
Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome
Yako, K., Kusunoki, S., & Kanazawa, I. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00174-4 · Cited by 46
Kashihara, K., Shiro, Y., KOGA, M., & Yuki, N. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.5.799 · Cited by 45
Differential Distribution of HLA Alleles in Two Forms of Guillain‐Barré Syndrome
Monos, D. S., Papaioakim, M., Ho, T. W., Li, C. Y., & McKhann, G. M. (1997) · The Journal of Infectious Diseases · doi:10.1086/513786 · Cited by 45
Cloning, expression, and characterization of the Escherichia coli K-12 rfaD gene
Pegues, J. N., Chen, L. S., Gordon, A., et al. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.8.4652-4660.1990 · Cited by 43
Geleijns, K. P. W., Laman, J. D., van Rijs, W., et al. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.12.001 · Cited by 43
IgG Fc-receptor polymorphisms in Guillain–Barre syndrome
Vedeler, C. A., Raknes, G., Myhr, K., et al. (2000) · Neurology · doi:10.1212/wnl.55.5.705 · Cited by 43
Guillain-Barré syndrome after transplantation
Zhang, L., Arrington, S., & Keung, Y. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190701760003 · Cited by 42
Koga, M., Yuki, N., Kashiwase, K., et al. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00072-1 · Cited by 42
Geleijns, K. P. W., Jacobs, B. C., van Rijs, W., et al. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.01.003 · Cited by 41
Interleukin-10 promoter polymorphisms in patients with Guillain–Barré syndrome
Myhr, K. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00133-4 · Cited by 41
Taguchi, K., Ren, J., Utsunomiya, I., et al. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.07.011 · Cited by 40
Ganglioside Mimicry as a Cause of Guillain-Barre Syndrome
Komagamine, T., & Yuki, N. (2006) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152706777950765 · Cited by 39
Press, R., Nennesmo, I., Kouwenhoven, M. C. M., Huang, Y.-M., Link, H., & Pashenkov, M. V. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.09.020 · Cited by 39
Antiglycolipid Antibodies in Guillain-Barr?? Syndrome and Autoimmune Neuropathies
Kusunoki, S. (2000) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200004000-00006 · Cited by 38
Antibodies to GT1a ganglioside in patients with Guillain–Barré syndrome
Ilyas, A. A., Cook, S. D., Mithen, F. A., et al. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00197-5 · Cited by 37
Reduced circulating CD4+CD25+ cell populations in Guillain–Barré syndrome
Pritchard, J., Makowska, A. M., Gregson, N. A., et al. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.12.002 · Cited by 36
Yuki, N. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04707.x · Cited by 36
Ataxic form of Guillain-Barre syndrome associated with anti-GD1b IgG antibody
Yuki, N., Susuki, K., & Hirata, K. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.1.136 · Cited by 36
Ganglioside complexes: new autoantibody targets in Guillain–Barré syndromes
Willison, H. J. (2005) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0001 · Cited by 34
Susceptibility to Guillain–Barré syndrome is not associated with CD1A and CD1E gene polymorphisms
Kuijf, M. L., Geleijns, K. P. W., Ennaji, N., van Rijs, W., van Doorn, P. A., & Jacobs, B. C. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.08.013 · Cited by 34
Familial Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis
Yuki, N., & Tsujino, Y. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70539-2 · Cited by 34
Association of Tumor Necrosis Factor Polymorphisms with Guillain-Barré Syndrome
Zhang, J., Dong, H., Li, B., et al. (2007) · European Neurology · doi:10.1159/000102162 · Cited by 33
Klena, J. D., Gray, S. A., & Konkel, M. E. (1998) · Gene · doi:10.1016/s0378-1119(98)00501-0 · Cited by 33
Pathogenesis of Guillain–Barré syndrome
Tsang, R. S. W., & Valdivieso-García, A. (2003) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.1.4.597 · Cited by 30
Recent studies on the roles of antiglycosphingolipids in the pathogenesis of neurological disorders
Ariga, T., Miyatake, T., & Yu, R. K. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1162 · Cited by 29
Self-citationProminent sensory ataxia in Guillain–Barré syndrome associated with IgG anti-GD1b antibody
Wicklein, E. M., Pfeiffer, G., Yuki, N., et al. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00136-6 · Cited by 29
The role of IL‐12 and TNF‐α in AIDP and AMAN
Deng, H., Yang, X., Jin, T., et al. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02261.x · Cited by 28
CDR3 spectratyping analysis of the T cell receptor repertoire in Guillain–Barré and Fisher syndromes
Koga, M., Yuki, N., Tsukada, Y., Hirata, K., & Matsumoto, Y. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00212-1 · Cited by 28
Yuki, N. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000714 · Cited by 27
Polymorphisms of CD1 genes in chronic dysimmune neuropathies
Angelis, M. V. D., Notturno, F., Caporale, C. M., et al. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.03.001 · Cited by 27
Phongsisay, V., Perera, V. N., & Fry, B. N. (2006) · Infection and Immunity · doi:10.1128/iai.74.2.1368-1372.2006 · Cited by 27
Usuki, S., Thompson, S. A., Rivner, M. H., Taguchi, K., Shibata, K., Ariga, T., & Yu, R. K. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20717 · Cited by 25
Self-citationFisher's syndrome and group A streptococcal infection
Yuki, N., & Hirata, K. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00220-2 · Cited by 24
Isolation and genotype analysis of rubella virus from a case of Guillain-Barré syndrome
Figueiredo, C. A., Klautau, G. B., Afonso, A. M. S., et al. (2008) · Journal of Clinical Virology · doi:10.1016/j.jcv.2008.07.015 · Cited by 24
Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barre syndrome
Koga, M., Takahashi, M., Masuda, M., Hirata, K., & Yuki, N. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.01.002 · Cited by 24
FAMILIAL GUILLAIN-BARRE SYNDROME
Saunders, M. J., & Rake, M. O. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90067-x · Cited by 24
HLA and anti-GQ1b IgG antibody in Miller Fisher syndrome and Guillain-Barré syndrome
Chiba, A., Kusunoki, S., Kuwata, S., et al. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00079-h · Cited by 23
Godschalk, P. C. R., Bergman, M. P., Gorkink, R. F. J., et al. (2006) · BMC Microbiology · doi:10.1186/1471-2180-6-32 · Cited by 23
No association with HLA-DR, -DQ or -DP alleles in Guillain-Barré syndrome
Hillert, J. A., OSTERMAN, P. O., & Olerup, O. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90088-o · Cited by 21
Shu, X. M., Cai, F. C., & Zhang, X. P. (2005) · Muscle & Nerve · doi:10.1002/mus.20457 · Cited by 21
Anti-GQ1b antibody does not affect neuromuscular transmission in human limb muscle
Kuwabara, S., Misawa, S., Takahashi, H., Sawai, S., Kanai, K., Nakata, M., Mori, M., Hattori, T., & Yuki, N. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.07.001 · Cited by 21
Wals, P. D., Deceuninck, G., Boucher, R., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/533469 · Cited by 20
Characterization of some minor gangliosides in Tay—Sachs brains
Yu, R. K., Itoh, T., Yohe, H. C., et al. (1983) · Brain Research · doi:10.1016/0006-8993(83)90415-8 · Cited by 20
Self-citationVriesendorp, F. J., Triggs, W. J., Mayer, R. F., et al. (1995) · Journal of Neurology · doi:10.1007/bf00873550 · Cited by 19
Nakatani, Y., Hotta, S., Utsunomiya, I., Tanaka, K., Hoshi, K., Ariga, T., Yu, R. K., Miyatake, T., & Taguchi, K. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9735-4 · Cited by 18
Self-citation
Research works printed but not linked: 10
- Bullens, 2002, Journal of Neuroscience, 22, 6876
- 2005, 22, 763
- 1998, 222, 177
- Kusunoki, 1999, Annals of neurology, 45, 400, 10.1002/1531-8249(199903)45:3<400::AID-ANA19>3.0.CO;2-Y · doi:10.1002/1531-8249(199903)45:3<400::aid-ana19>3.0.co;2-y
- Kusunoki, 1997, Muscle & nerve, 20, 840, 10.1002/(SICI)1097-4598(199707)20:7<840::AID-MUS8>3.0.CO;2-7 · doi:10.1002/(sici)1097-4598(199707)20:7<840::aid-mus8>3.0.co;2-7
- Ogawara, 2000, Annals of neurology, 48, 624, 10.1002/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O · doi:10.1002/1531-8249(200010)48:4<624::aid-ana9>3.0.co;2-o · Paper page
- Reuben, 2003, Neurology India, 51, 487
- Ropper, 1986, Archives of Neurology, 43, 1150, 10.1001/archneur.43.11.1150 · doi:10.1001/archneur.43.11.1150
- 2004, The Journal of Lipid Research, 45, 783, 10.1194/jlr.R300020-JLR200 · doi:10.1194/jlr.r300020-jlr200 · Paper page
- Yuki, 2000, Annals of neurology, 47, 314, 10.1002/1531-8249(200003)47:3<314::AID-ANA6>3.0.CO;2-C · doi:10.1002/1531-8249(200003)47:3<314::aid-ana6>3.0.co;2-c
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“In the latter instance rare human immune responses against the ganglioside-like structures can even result in serious illness, with the complement-fixing antibodies damaging peripheral nerves (Guillain-Barré syndrome) (990, 991).”
BackgroundStructures, Biosynthesis, and Functions of Gangliosides-an Overview
Yu, R. K., Tsai, Y.-T., Ariga, T., & Yanagisawa, M. (2011) · Journal of Oleo Science · doi:10.5650/jos.60.537 · Cited by 416
Self-citationEpidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome
Keddie, S., Pakpoor, J., Mousele, C., Pipis, M., Machado, P. M., Foster, M., Record, C. J., Keh, R. Y. S., Fehmi, J., Paterson, R. W., et al. (2021) · Brain · doi:10.1093/brain/awaa433 · Cited by 333
Metadata
- Authors
- Kaida, K., Ariga, T., & Yu, R. K.
- Affiliations
- Augusta University (US)
- ORCID
- Yu, R. K
- Venue
- Glycobiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-02-24
- Volume
- 19
- Issue
- 7
- Pages
- 676-692
- ISSN
- 0959-6658 (ISSN-L)
- 1460-2423
- PMC
- PMC2688390
- OpenAlex
- W2097643820
- Cited by
- 155
- References
- 226
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 3 · 2023: 11 · 2022: 14 · 2021: 9 · 2020: 16 · 2019: 11 · 2018: 4 · 2017: 4 · 2016: 9 · 2015: 5 · 2014: 8 · 2013: 4 · 2012: 10
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Glycobiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (R01NS011853, R01NS026994, NS26994, NS-11 853)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
- Keywords
- Guillain-Barré syndrome, anti-ganglioside antibodies, gangliosides, lipooligosaccharide, molecular mimicry, Campylobacter jejuni, autoantibodies, GD1a, GM1, HLA, polyradiculoneuropathy, pathogenesis, infection-triggered autoimmunity
- MeSH terms
- Animals, Antigen-Antibody Reactions, Autoantibodies, Gangliosides, Humans, Lipopolysaccharides, Molecular Mimicry, Guillain-Barre Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.